Contract 75A50123C00055

Rafa Laboratories Ltd · Department Of Health And Human Services · September 19, 2023

Cost Plus Fixed FeeFull & Open CompetitionNAICS 541714

Rafa Laboratories Ltd was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 19, 2023 for $9.37 million of work in research and development in biotechnology (except nanobiotechnology). It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost-plus contract pricing. The most recent modification was on September 22, 2025. If all options are exercised, the contract could reach $14.72 million.

Obligated to date
$9.37M
$9,371,145
Current value
$9.37M
Potential value
$14.72M
if all options exercised
Modifications
2
Latest September 22, 2025

Contract details

PIID
75A50123C00055
Award type
Definitive Contract
Pricing
Cost Plus Fixed Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
Product / service
Health R&D Services; Health Care Services; Experimental Development
First action
September 19, 2023
Latest action
September 22, 2025

Description

SUPPLEMENTAL FUNDING FOR CLIN 001, REVISE STATEMENT OF WORK, ADD ALT COR, AND ADD ATTACHMENT 7 EO FAR CLAUSE CHANGES.

Modification timeline

  • September 22, 2025
    Mod P00002
    $1.67M
  • August 14, 2024
    Mod P00001
    THE PURPOSE OF THIS MODIFICATION IS TO UPDATE SECTION E.1 INSPECTION AND ACCEPTANCE, SECTION F.3.2.E OTHER REQUIREMENTS/DELIVERABLES, SECTION G.1 CONTRACTING OF
    $0
  • September 19, 2023
    Base award
    THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT, INCLUDING U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL, OF ATROPINE AUTOINJECTOR FOR P
    $7.70M

Similar contracts

RecipientAgencyDateObligated
Vericel CorporationDepartment Of Health And Human ServicesApril 1, 2026$34.88M
Ceramedix Holding, LlcDepartment Of Health And Human ServicesMarch 31, 2026$4.22M
American College Of Medical Toxicology, Inc.Department Of Health And Human ServicesMarch 31, 2026$0
Glaxosmithkline, LlcDepartment Of Health And Human ServicesMarch 31, 2026$7.79M
Care Access Research LlcDepartment Of Health And Human ServicesMarch 31, 2026$2.55M
Pattern Bioscience, Inc.Department Of Health And Human ServicesMarch 31, 2026$22.50M

Top contractors in NAICS 541714

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75A50123C00055?

Contract 75A50123C00055 is a federal contract awarded to Rafa Laboratories Ltd by Department Of Health And Human Services on September 19, 2023 for $9.37 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.

Who won contract 75A50123C00055?

Rafa Laboratories Ltd won contract 75A50123C00055 from Department Of Health And Human Services.

How much is contract 75A50123C00055 worth?

Contract 75A50123C00055 has obligated $9.37 million to date, with a total potential value of $14.72 million if all options are exercised.